Charles Robertson

Dr. Charles Robertson

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Science
Verified
Journal Article
Closed access
PDF file
JMJanet G. M. Markle
Janet G. M. Markle
DFDaniel N. Frank
Daniel N. Frank
SMSteven Mortin-Toth
Steven Mortin-Toth
CRCharles Robertson
Charles Robertson
LFLeah M. Feazel
Leah M. Feazel
JDJayne S. Danska
Jayne S. Danska
Mighty Male Microbes: Both genetic and environmental factors contribute to an individual's susceptibility to autoimmune disease, but the specific environmental influences are not well characterized. Markle et al. (p. 1084 , published online 17 January; see the Perspective by Flak et al. ) explored how microbial factors, in particular the gut microbiota, influence susceptibility to type 1 diabetes in mice. In the non-obese diabetic (NOD) mouse model of type 1 diabetes, female mice are significantly more susceptible to disease than males; however, this difference was not apparent under germ-free conditions. Transfer of cecal contents from male NOD mice to female NOD mice prior to disease onset protected against pancreatic islet inflammation, autoantibody production, and the development of diabetes and was associated with increased testosterone in female mice. Blocking androgen receptor activity abrogated protection. Thus, the microbiota may be able to regulate sex hormones and influence an individual's susceptibility to autoimmunity.

1 January 2011 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
DFDaniel N. Frank
Daniel N. Frank
CRCharles Robertson
Charles Robertson
CHChristina M. Hamm
Christina M. Hamm
ZKZegbeh Kpadeh
Zegbeh Kpadeh
TZTianyi Zhang
Tianyi Zhang
ELEllen Li
Ellen Li
Background. Abnormal host–microbe interactions are implicated in the pathogenesis of inflammatory bowel diseases. Previous 16S rRNA sequence analysis of intest

8 January 2014 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
SDS M Dillon
S M Dillon
ELE J Lee
E J Lee
CKC V Kotter
C V Kotter
GAGregory Austin
Gregory Austin
ZDZ Dong
Z Dong
CWC C Wilson
C C Wilson
Human immunodeficiency virus-1 (HIV-1) infection disrupts the intestinal immune system, leading to microbial translocation and systemic immune activation. We investigated the impact of HIV-1 infection on the intestinal microbiome and its association with mucosal T-cell and dendritic cell (DC) frequency and activation, as well as with levels of systemic T-cell activation, inflammation, and microbial translocation. Bacterial 16S ribosomal DNA sequencing was performed on colon biopsies and fecal samples from subjects with chronic, untreated HIV-1 infection and uninfected control subjects. Colon biopsies of HIV-1-infected subjects had increased abundances of Proteobacteria and decreased abundances of Firmicutes compared with uninfected donors. Furthermore at the genus level, a significant increase in Prevotella and decrease in Bacteroides was observed in HIV-1-infected subjects, indicating a disruption in the Bacteroidetes bacterial community structure. This HIV-1-associated increase in Prevotella abundance was associated with increased numbers of activated colonic T cells and myeloid DCs. Principal coordinates analysis demonstrated an HIV-1-related change in the microbiome that was associated with increased mucosal cellular immune activation, microbial translocation, and blood T-cell activation. These observations suggest that an important relationship exists between altered mucosal bacterial communities and intestinal inflammation during chronic HIV-1 infection.

15 November 2013 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
EGElena Goleva
Elena Goleva
LJLeisa P. Jackson
Leisa P. Jackson
JHJ. Kirk Harris
J. Kirk Harris
CRCharles Robertson
Charles Robertson
ESE. Rand Sutherland
E. Rand Sutherland
DLDonald Y.M. Leung
Donald Y.M. Leung
Rationale: The role of airway microbiome in corticosteroid response in asthma is unknown. Objectives: To examine airway microbiome composition in patients with corticosteroid-resistant (CR) asthma and compare it with patients with corticosteroid-sensitive (CS) asthma and normal control subjects and explore whether bacteria in the airways of subjects with asthma may direct alterations in cellular responses to corticosteroids. Methods: 16S rRNA gene sequencing was performed on bronchoalveolar lavage (BAL) samples of 39 subjects with asthma and 12 healthy control subjects. In subjects with asthma, corticosteroid responsiveness was characterized, BAL macrophages were stimulated with pathogenic versus commensal microorganisms, and analyzed by real-time polymerase chain reaction for the expression of corticosteroid-regulated genes and cellular p38 mitogen-activated protein kinase (MAPK) activation. Measurements and Main Results: Of the 39 subjects with asthma, 29 were CR and 10 were CS. BAL microbiome from subjects with CR and CS asthma did not differ in richness, evenness, diversity, and community composition at the phylum level, but did differ at the genus level, with distinct genus expansions in 14 subjects with CR asthma. Preincubation of asthmatic airway macrophages with Haemophilus parainfluenzae, a uniquely expanded potential pathogen found only in CR asthma airways, resulted in p38 MAPK activation, increased IL-8 (P < 0.01), mitogen-activated kinase phosphatase 1 mRNA (P < 0.01) expression, and inhibition of corticosteroid responses (P < 0.05). This was not observed after exposure to commensal bacterium Prevotella melaninogenica. Inhibition of transforming growth factor-β–associated kinase-1 (TAK1), upstream activator of MAPK, but not p38 MAPK restored cellular sensitivity to corticosteroids. Conclusions: A subset of subjects with CR asthma demonstrates airway expansion of specific gram-negative bacteria, which trigger TAK1/MAPK activation and induce corticosteroid resistance. TAK1 inhibition restored cellular sensitivity to corticosteroids.

10 September 2013 in Bioinformatics
Verified
Journal Article
Open access
PDF file
CRCharles Robertson
Charles Robertson
JHJ. Kirk Harris
J. Kirk Harris
BWBrandie D. Wagner
Brandie D. Wagner
DGDavid Granger
David Granger
KBKathy Browne
Kathy Browne
DFDaniel Frank
Daniel Frank
Summary: Studies of the human microbiome, and microbial community ecology in general, have blossomed of late and are now a burgeoning source of exciting research findings. Along with the advent of next-generation sequencing platforms, which have dramatically increased the scope of microbiome-related projects, several high-performance sequence analysis pipelines (e.g. QIIME, MOTHUR, VAMPS) are now available to investigators for microbiome analysis. The subject of our manuscript, the graphical user interface-based Explicet software package, fills a previously unmet need for a robust, yet intuitive means of integrating the outputs of the software pipelines with user-specified metadata and then visualizing the combined data. Availability and Implementation: Explicet is implemented in C++ via the Qt framework and supported in native code on all major operating systems (Windows, Macintosh, Linux). The source code, documents and tutorials are freely available under an open-source license at www.explicet.org. Contact:daniel.frank@ucdenver.edu

17 January 2012 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
LFLeah M. Feazel
Leah M. Feazel
CRCharles Robertson
Charles Robertson
VRVijay R. Ramakrishnan
Vijay R. Ramakrishnan
DFDaniel Frank
Daniel Frank